Vishakha Anu

Vishakha Anu

Profile ID RP-003-1122 Joined 2025-01-27 5 articles
0Connections
3
Total Views
5
Total Publications
152
Publication Views

Articles(5)

Authors: Vishakha Anu, Shruthi Shivdas, Pallavi Ram

DOI: 10.33545/gynae.2026.v10.i1g.1919

Volume10
Issue1
Pages525-528
Abstract

Background:Mature cystic teratoma is the most common ovarian neoplasm of adolescent and reproductive age group. Squamous cell carcinomas account for most common type of somatic transformation followed by adenocarcinoma. Case Summary: We present a case series of 4 patients with 4 different types of malignant transformation in dermoid and their management at our Institute. The types include Mucinous Adenocarcinoma, Anaplastic Ependymoma, and Rhabdomyosarcoma besides Squamous Cell Carcinoma. Conclusion Malignant degeneration is rare and continues to be evasive in literature, posing detection and management difficulties. A large dermoid of >10cm in a post-menopausal lady, with a solid enhancing component should arouse suspicion of MT-MCT, especially with deranged serum markers. Overall, treatment must be dictated by the transformed malignant histology. Metastatic tumors must be differentiated from MT-MCTs. It can be safely said that there are no standard rules for these entities in terms of clinico-pathological behaviour, management or prognosis. What needs to be done is to keep a high index of suspicion, as to avoid violation of oncological principles.

Authors: Manisha Gupta, Vishakha Anu, Abhishek Kumar

DOI: 10.25259/ijcdw_13_2025

Volume5
Issue1
Pages1-12
Abstract

Cerebral venous thrombosis (CVT) is a rare but significant cause of stroke in young women, accounting for 0.5–1% of all cerebrovascular events, with hormonal factors playing a central etiological role. This comprehensive review examines the relationship between exogenous hormonal use – including oral contraceptives (OCPs), non-oral preparations, and hormone replacement therapy (HRT) and CVT risk in women. A broad literature search was undertaken using PubMed, Cochrane Library, Excerpta Medica Database (EMBASE), Scopus, and other databases, focusing on studies published after 2005. The analysis demonstrates that estrogen-containing combined oral contraceptives (COCs) increase the risk of CVT approximately 5–7 times compared with non-users, predominantly due to estrogen-induced hypercoagulability through increased procoagulant factors and suppression of natural anticoagulants. This risk is further amplified in women with inherited thrombophilia such as Factor V Leiden and prothrombin G20210A mutations, obesity, or smoking. Third- and fourth-generation COCs, containing newer progestins like drospirenone or desogestrel, confer higher thrombogenic potential, while second-generation, low-dose levonorgestrel-based COCs exhibit relatively lower risk. Clinical manifestations of OCP-related CVT are nonspecific, with headache being the most frequent symptom, emphasizing the need for early magnetic resonance (MR) imaging or MR venography for diagnosis. Non-oral hormonal preparations (transdermal patches and vaginal rings) show a modest increase in thrombotic risk, though current evidence remains insufficient to confirm their safety for CVT specifically. Regarding HRT, epidemiological data indicate a 2–5-fold elevated venous thrombosis risk, with the highest risk during the 1 st year of therapy; oral HRT is associated with a greater thrombotic burden than transdermal formulations, as confirmed by the ESTHER study and recent meta-analyses. Overall, these findings underscore the importance of individualized risk assessment, especially for women with predisposing conditions such as thrombophilia, hypertension, or metabolic syndromes. In conclusion, low-dose, second-generation levonorgestrel-based COCs or progestin-only formulations are considered the safest hormonal options in women at risk of CVT, while transdermal estrogen remains the preferred route for menopausal hormone therapy.

Authors: Vishakha Anu, MRUS Sireesha, Pragnia Poloju, Pallavi V R

DOI: 10.25259/asjo_23_2025

Volume11
Issue11
Pages26
Abstract

Objectives: More than 90% of carcinoma cervix comprises squamous cell carcinoma and usual type adenocarcinoma, while rare histopathological variants constitute <5% of cases and pose diagnostic and therapeutic challenges. Material and Methods: We retrospectively reviewed patients with uncommon histotypes of invasive cervical cancer treated at our institute between September 2019 and September 2022. Cases of squamous cell carcinoma, usual-type adenocarcinoma, and adenosquamous carcinoma were excluded. Clinical features, imaging, management, histopathology, immunohistochemistry (IHC), and outcomes were analyzed. Results: Twelve patients were identified, with a median age of 40 years (range: 21–72). Histologies included neuroendocrine carcinoma (n=3), malignant melanoma (n=3), clear cell carcinoma (n=2), adenosarcoma (n=1), basaloid squamous cell carcinoma (n=1), lymphoma (n=1), and leiomyosarcoma (n=1). Postmenopausal bleeding was the most common presentation. Hyperpigmentation of the cervix was seen in all the cases of malignant melanoma. A pre-operative accurate diagnosis was made in 83.33% cases (10 out of 12). 2 cases of neuroendocrine carcinoma received neoadjuvant chemotherapy. In 4 cases, radical hysterectomy type C1 was done. IHC was essential but often showed overlapping features; only clear cell carcinoma was consistently human papillomavirus (HPV) independent. At the last follow-up, six patients remained asymptomatic. Conclusion: Rare cervical cancer histotypes are heterogeneous, diagnostically challenging, and often associated with poor outcomes. Histopathology supplemented by IHC remains central to diagnosis. Management should be individualized, as no standardized protocols exist. Larger multicentric studies are required to optimize treatment strategies.

Authors: Vishakha Anu, Roma Jethani, Sadaf Hayat

DOI: 10.1007/s40944-025-01028-7

Volume23
Issue3
Pages3
Abstract

Abstract Background Vaginal leiomyosarcoma is a rare and aggressive malignancy arising from smooth muscle cells in the vaginal wall. Amongst, vaginal sarcoma, leiomyosarcoma is the most common and comprised fewer than 2% of all malignant vaginal neoplasms. Case Summary A 50-year, post-hysterectomized women presented with slowly growing mass of vagina for two years. A pre-operative biopsy confirmed the diagnosis of vaginal leiomyosarcoma. Wide local excision followed by adjuvant radiation and five cycles of ifosfamide and adriamycin was planned by the tumor Board. Patient has tolerated the treatment well till date. Conclusion This case adds to the scarce data of vaginal sarcomas and highlights need of pre-operative diagnosis and optimal management of vaginal leiomyosarcomas.

Authors: Sangeeta Rai, Vishakha Anu, Raghunath S More

DOI: 10.5005/jp-journals-10006-1777

Volume12
Issue3
Pages192-195
Abstract

ABSTRACT Cesarean scar ectopic pregnancy (CSEP) is on the rise with increasing rate of cesarean section and better diagnostic modalities. Therefore, prompt and correct diagnosis and decision about treatment modality are important to reduce mortality and morbidity. Expertise of both gynecologist and radiologist is needed. High index of suspicion should be kept in mind, and any delay in management can lead to detrimental consequences. Here is a case series of three cases with CSEP and their conservative line of management. Diagnosis was made through history, clinical examination, serum beta-human chorionic gonadotropin (β-hCG) levels, ultrasound and hysteroscopy, and confirmed with histopathology also. Methotrexate was the primary treating modality in all the three cases, and the future fertility was preserved. The follow-up was by serum β-hCG and ultrasound scans. How to cite this article: Rai S, Anu V, More RS. Conservative Management of Cesarean Scar Ectopic Pregnancy: A Case Series. J South Asian Feder Obst Gynae 2020;12(3):192–195.

No matching articles

Try another word from the title, author or DOI.

Brief Bio

No bio added yet.

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Other Online Pages

Scholars in the same field

RP
Rakesh Pandit
0 publications
VK
Vinay Kumar
0 publications
NK
Nithis Kumar S
0 publications
SK
Shiva Kumar
0 publications
SD
Shubhra Dubey
0 publications
DN
DEEPTHY NAIR
0 publications
UG
UMER GULL KHAN
0 publications
SS
Satyaprakash Suman
0 publications
AK
Abhinav K P
0 publications

Following

Nobody here yet.

Followers

Nobody here yet.

5 Publications

0 Contributions

Nothing added yet.

Filter